Position in LGND
as of Jun 30, 2026
· filed Jul 21, 2026
Position Value
$796,546
New position
Shares Held
2,520
first reported quarter
Ownership
0.013%
of shares outstanding
% of Portfolio
0.43%
of 13F equity value
Holder Rank
#209
of 411 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 14%
Shared 0%
None 86%
Position in Biotechnology
Healthcare · as of Jun 30, 2026HMS Capital Management, LLC holds $1,294,264 across 2 Biotechnology names. LGND ranks #1 (61.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LGND |
Ligand Pharmaceuticals Inc
This page
|
2,520 | $796,546 | |
| 2 | HALO |
Halozyme Therapeutics, Inc.
|
6,359 | $497,718 |
All Filings in LGND
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $796,546 | 2,520 | Shares | Sole | 2026-07-21 | |
| No filing history on record for this holder in this stock. | ||||||